Greenwich Non Current Liabilities Total vs Net Debt Analysis
GLSI Stock | USD 13.40 0.19 1.44% |
Greenwich Lifesciences financial indicator trend analysis is much more than just examining Greenwich Lifesciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Greenwich Lifesciences is a good investment. Please check the relationship between Greenwich Lifesciences Non Current Liabilities Total and its Net Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.
Non Current Liabilities Total vs Net Debt
Non Current Liabilities Total vs Net Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Greenwich Lifesciences Non Current Liabilities Total account and Net Debt. At this time, the significance of the direction appears to have strong relationship.
The correlation between Greenwich Lifesciences' Non Current Liabilities Total and Net Debt is 0.71. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Net Debt in the same time period over historical financial statements of Greenwich Lifesciences, assuming nothing else is changed. The correlation between historical values of Greenwich Lifesciences' Non Current Liabilities Total and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Greenwich Lifesciences are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Non Current Liabilities Total i.e., Greenwich Lifesciences' Non Current Liabilities Total and Net Debt go up and down completely randomly.
Correlation Coefficient | 0.71 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Non Current Liabilities Total
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Most indicators from Greenwich Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Greenwich Lifesciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.The Greenwich Lifesciences' current Enterprise Value is estimated to increase to about 240.3 M, while Selling General Administrative is projected to decrease to under 1.2 M.
2021 | 2023 | 2024 (projected) | Reconciled Depreciation | 3.6K | 4.2K | 4.0K | Total Operating Expenses | 4.6M | 9.3M | 5.3M |
Greenwich Lifesciences fundamental ratios Correlations
Click cells to compare fundamentals
Greenwich Lifesciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Greenwich Lifesciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 26.7K | 28.7M | 27.2M | 13.5M | 7.0M | 6.6M | |
Other Current Liab | 646.8K | 770.3K | 164.3K | 42.1K | 258.9K | 311.1K | |
Total Current Liabilities | 1.4M | 1.0M | 385.2K | 262.9K | 294.4K | 545.8K | |
Total Stockholder Equity | (1.4M) | 27.6M | 26.8M | 13.2M | 6.7M | 11.5M | |
Net Debt | (6.2K) | (28.7M) | (27.2M) | (13.5M) | (7.0M) | (7.3M) | |
Retained Earnings | (27.2M) | (29.1M) | (33.6M) | (41.5M) | (50.4M) | (52.9M) | |
Cash | 6.8K | 28.7M | 27.2M | 13.5M | 7.0M | 6.6M | |
Non Current Assets Total | 19.8K | 16.2K | 12.6K | 9.0K | 5.4K | 5.1K | |
Cash And Short Term Investments | 6.8K | 28.7M | 27.2M | 13.5M | 7.0M | 6.6M | |
Common Stock Shares Outstanding | 11.7M | 12.7M | 12.9M | 12.9M | 12.8M | 13.8M | |
Liabilities And Stockholders Equity | 26.7K | 28.7M | 27.2M | 13.5M | 7.0M | 6.6M | |
Other Stockholder Equity | 25.9M | 56.7M | 60.5M | 54.7M | 57.1M | 49.2M | |
Total Liab | 1.4M | 1.0M | 385.2K | 262.9K | 294.4K | 279.7K | |
Net Invested Capital | (1.4M) | 27.6M | 26.8M | 13.2M | 6.7M | 11.5M | |
Total Current Assets | 6.8K | 28.7M | 27.2M | 13.5M | 7.0M | 6.6M | |
Capital Stock | 10.4K | 12.7K | 13.1K | 12.8K | 14.8K | 11.8K | |
Net Working Capital | (1.4M) | 27.6M | 26.8M | 13.2M | 6.7M | 13.3M | |
Intangible Assets | 19.8K | 16.2K | 12.6K | 9.0K | 5.4K | 5.1K | |
Common Stock | 8.5K | 12.7K | 13.1K | 12.8K | 14.8K | 11.0K |
Currently Active Assets on Macroaxis
When determining whether Greenwich Lifesciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Greenwich Lifesciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Greenwich Lifesciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Greenwich Lifesciences Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.81) | Return On Assets (0.72) | Return On Equity (1.24) |
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Greenwich Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.